Whether stroke or hypertension modifies or mediates the relationship between particulate matter exposure and dementia.
Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer
Combination therapy with enfortumab vedotin (Padcev) and pembrolizumab (Keytruda) was associated with durable responses and meaningful survival in cisplatin-ineligible patients with locally advanced or metastatic